These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 18983509

  • 41. 15-deoxy-delta12,14-prostaglandin J2-mediated ERK signaling inhibits gram-negative bacteria-induced RelA phosphorylation and interleukin-6 gene expression in intestinal epithelial cells through modulation of protein phosphatase 2A activity.
    Ruiz PA, Kim SC, Sartor RB, Haller D.
    J Biol Chem; 2004 Aug 20; 279(34):36103-11. PubMed ID: 15199053
    [Abstract] [Full Text] [Related]

  • 42. 15-deoxy-delta-12-14-PGJ2 regulates apoptosis induction and nuclear factor-kappaB activation via a peroxisome proliferator-activated receptor-gamma-independent mechanism in hepatocellular carcinoma.
    Okano H, Shiraki K, Inoue H, Yamanaka Y, Kawakita T, Saitou Y, Yamaguchi Y, Enokimura N, Yamamoto N, Sugimoto K, Murata K, Nakano T.
    Lab Invest; 2003 Oct 20; 83(10):1529-39. PubMed ID: 14563954
    [Abstract] [Full Text] [Related]

  • 43. 15-deoxy-Δ¹²,¹⁴ -prostaglandin J₂ inhibits human immunodeficiency virus-1 tat-induced monocyte chemoattractant protein-1/CCL2 production by blocking the extracellular signal-regulated kinase-1/2 signaling pathway independently of peroxisome proliferator-activated receptor-γ and heme oxygenase-1 in rat hippocampal slices.
    Kim SE, Lee EO, Yang JH, Kang JH, Suh YH, Chong YH.
    J Neurosci Res; 2012 Sep 20; 90(9):1732-42. PubMed ID: 22487967
    [Abstract] [Full Text] [Related]

  • 44. The 15-deoxy-Delta12,14-prostaglandin J2 inhibits LPS-stimulated AKT and NF-kappaB activation and suppresses interleukin-6 in osteoblast-like cells MC3T3E-1.
    Jung WK, Park IS, Park SJ, Yea SS, Choi YH, Oh S, Park SG, Choi IW.
    Life Sci; 2009 Jul 03; 85(1-2):46-53. PubMed ID: 19409914
    [Abstract] [Full Text] [Related]

  • 45. 15-Deoxy-Δ(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner.
    Martínez AE, Sánchez-Gómez FJ, Díez-Dacal B, Oeste CL, Pérez-Sala D.
    Inflamm Allergy Drug Targets; 2012 Feb 03; 11(1):58-65. PubMed ID: 22309084
    [Abstract] [Full Text] [Related]

  • 46. 15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53.
    Ho TC, Chen SL, Yang YC, Chen CY, Feng FP, Hsieh JW, Cheng HC, Tsao YP.
    J Biol Chem; 2008 Oct 31; 283(44):30273-88. PubMed ID: 18718914
    [Abstract] [Full Text] [Related]

  • 47. Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions.
    Ueki S, Kato H, Kobayashi Y, Ito W, Adachi T, Nagase H, Ohta K, Kayaba H, Chihara J.
    Int Arch Allergy Immunol; 2007 Oct 31; 143 Suppl 1():15-22. PubMed ID: 17541271
    [Abstract] [Full Text] [Related]

  • 48. Induction of apoptosis by 15d-PGJ2 via ROS formation: an alternative pathway without PPARγ activation in non-small cell lung carcinoma A549 cells.
    Wang JJ, Mak OT.
    Prostaglandins Other Lipid Mediat; 2011 Apr 31; 94(3-4):104-11. PubMed ID: 21396480
    [Abstract] [Full Text] [Related]

  • 49. Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages.
    Kim HY, Kim HK, Kim JR, Kim HS.
    Immunol Cell Biol; 2005 Jun 31; 83(3):286-93. PubMed ID: 15877607
    [Abstract] [Full Text] [Related]

  • 50. 15-Deoxy-Δ¹²,¹⁴-prostaglandin J₂-glycerol, a putative metabolite of 2-arachidonyl glycerol and a peroxisome proliferator-activated receptor γ ligand, modulates nuclear factor of activated T cells.
    Raman P, Kaplan BL, Kaminski NE.
    J Pharmacol Exp Ther; 2012 Sep 31; 342(3):816-26. PubMed ID: 22700433
    [Abstract] [Full Text] [Related]

  • 51. 15-deoxy-Delta12,14-prostaglandin J2 negatively regulates rankl gene expression in activated T lymphocytes: role of NF-kappaB and early growth response transcription factors.
    Fionda C, Nappi F, Piccoli M, Frati L, Santoni A, Cippitelli M.
    J Immunol; 2007 Apr 01; 178(7):4039-50. PubMed ID: 17371958
    [Abstract] [Full Text] [Related]

  • 52. 15-Deoxy-Delta(12,14)-prostaglandin J(2) facilitates thyroglobulin production by cultured human thyrocytes.
    Kasai K, Banba N, Hishinuma A, Matsumura M, Kakishita H, Matsumura M, Motohashi S, Sato N, Hattori Y.
    Am J Physiol Cell Physiol; 2000 Dec 01; 279(6):C1859-69. PubMed ID: 11078701
    [Abstract] [Full Text] [Related]

  • 53. Upregulation of VEGF by 15-deoxy-Delta12,14-prostaglandin J2 via heme oxygenase-1 and ERK1/2 signaling in MCF-7 cells.
    Kim EH, Na HK, Surh YJ.
    Ann N Y Acad Sci; 2006 Dec 01; 1090():375-84. PubMed ID: 17384282
    [Abstract] [Full Text] [Related]

  • 54. Activation of peripheral kappa/delta opioid receptors mediates 15-deoxy-(Delta12,14)-prostaglandin J2 induced-antinociception in rat temporomandibular joint.
    Pena-dos-Santos DR, Severino FP, Pereira SA, Rodrigues DB, Cunha FQ, Vieira SM, Napimoga MH, Clemente-Napimoga JT.
    Neuroscience; 2009 Nov 10; 163(4):1211-9. PubMed ID: 19647045
    [Abstract] [Full Text] [Related]

  • 55. 15-Deoxy-delta12,14-PGJ2 inhibits IL-6-induced Stat3 phosphorylation in lymphocytes.
    Kim HJ, Rho YH, Choi SJ, Lee YH, Cheon H, Um JW, Sohn J, Song GG, Ji JD.
    Exp Mol Med; 2005 Jun 30; 37(3):179-85. PubMed ID: 16000871
    [Abstract] [Full Text] [Related]

  • 56. 15d-Deoxy-Delta12,14-prostaglandin J2 modulates collagen type I synthesis in human hepatic stellate cells by inducing oxidative stress.
    Kim KA, Lim YS, Kim KM, Yoon JH, Lee HS.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Nov 30; 73(5):361-7. PubMed ID: 16098720
    [Abstract] [Full Text] [Related]

  • 57. 15-Deoxy-Δ12,14-prostaglandin J2 enhanced the anti-tumor activity of camptothecin against renal cell carcinoma independently of topoisomerase-II and PPARγ pathways.
    Yamamoto Y, Fujita M, Koma H, Yamamori M, Nakamura T, Okamura N, Yagami T.
    Biochem Biophys Res Commun; 2011 Jul 08; 410(3):563-7. PubMed ID: 21683069
    [Abstract] [Full Text] [Related]

  • 58. 15-deoxy-Delta12,14-prostaglandin J2 inhibits transcriptional activity of estrogen receptor-alpha via covalent modification of DNA-binding domain.
    Kim HJ, Kim JY, Meng Z, Wang LH, Liu F, Conrads TP, Burke TR, Veenstra TD, Farrar WL.
    Cancer Res; 2007 Mar 15; 67(6):2595-602. PubMed ID: 17363578
    [Abstract] [Full Text] [Related]

  • 59. 15-Deoxy-Δ12,14-Prostaglandin J2 Exerts Proresolving Effects Through Nuclear Factor E2-Related Factor 2-Induced Expression of CD36 and Heme Oxygenase-1.
    Kim W, Lee HN, Jang JH, Kim SH, Lee YH, Hahn YI, Ngo HK, Choi Y, Joe Y, Chung HT, Chen Y, Cha YN, Surh YJ.
    Antioxid Redox Signal; 2017 Dec 10; 27(17):1412-1431. PubMed ID: 28398824
    [Abstract] [Full Text] [Related]

  • 60. 15-Deoxy-delta 12,14-prostaglandins D2 and J2 are potent activators of human eosinophils.
    Monneret G, Li H, Vasilescu J, Rokach J, Powell WS.
    J Immunol; 2002 Apr 01; 168(7):3563-9. PubMed ID: 11907120
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.